Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T00:16:40.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page has been updated to include new drug information related to breast cancer treatments, specifically anthracycline and cyclophosphamide, while significant details about a previous study on nivolumab and its associated criteria have been removed.
    Difference
    11%
    Check dated 2025-04-22T18:08:33.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 8, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-08T10:13:20.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of January 8, 2025, and version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T07:57:57.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T12:59:21.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.8%
    Check dated 2025-02-16T08:15:45.000Z thumbnail image

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.